E Wilson Grandin1, Jose I Nunez2, Brooks Willar3, Kevin Kennedy4, Peter Rycus5, Joseph E Tonna6, Navin K Kapur7, Shahzad Shaefi8, A Reshad Garan9. 1. Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. Electronic address: wgrandin@bidmc.harvard.edu. 2. Department of Medicine. Montefiore Medical Center, Bronx, New York, USA. 3. Division of Cardiovascular Medicine, UMass Memorial Medical Center, Worcester, Massachusetts, USA. 4. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 5. Extracorporeal Life Support Organization, Ann Arbor, Michigan, USA. 6. Extracorporeal Life Support Organization, Ann Arbor, Michigan, USA; Division of Cardiothoracic Surgery and Emergency Medicine, University of Utah, Salt Lake City, Utah, USA. 7. The Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts, USA. 8. Division of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 9. Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Abstract
BACKGROUND: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) increases left ventricular (LV) afterload, potentially provoking LV distention and impairing recovery. LV mechanical unloading (MU) with intra-aortic balloon pump (IABP) or percutaneous ventricular assist device (pVAD) can prevent LV distension, potentially at the risk of more complications, and net clinical benefit remains uncertain. OBJECTIVES: This study aims to determine the association between MU and outcomes for patients undergoing VA-ECMO. METHODS: The authors queried the Extracorporeal Life Support Organization registry for adults receiving peripheral VA-ECMO from 2010 to 2019 and stratified them by MU with IABP or pVAD. The primary outcome was in-hospital mortality; secondary outcomes included on-support mortality and complications during VA-ECMO. RESULTS: Among 12,734 VA-ECMO patients, 3,399 (26.7%) received MU: 2,782 (82.9%) IABP and 580 (17.1%) pVAD. MU patients were older (age 56.3 vs 52.7 years) and, before extracorporeal membrane oxygenation, more often required >2 vasopressors (41.7% vs 27.2%) and had respiratory (21.1% vs 15.9%), renal (24.6% vs 15.8%), and liver failure (4.4% vs 3.1%) (all P < 0.001). MU patients had lower in-hospital mortality (56.6% vs 59.3%, P = 0.006), which persisted in multivariable modeling (adjusted OR [aOR]: 0.84; 95% CI: 0.77-0.92; P < 0.001). MU was associated with more cannula site bleeding (aOR: 1.25; 95% CI: 1.11-1.40; P < 0.001) and hemolysis (aOR: 1.27; 95% CI: 1.03-1.57; P = 0.02). Compared to pVAD, MU patients with IABP had similar mortality (aOR: 0.80; 95% CI: 0.64-1.01; P = 0.06) and less medical bleeding (aOR: 0.45; 95% CI: 0.31-0.64; P < 0.001), cannula site bleeding (aOR: 0.72; 95% CI: 0.54-0.96; P = 0.03), and renal injury (aOR: 0.78; 95% CI: 0.62-0.98; P = 0.03). CONCLUSIONS: Among adults receiving VA-ECMO, MU was associated with lower in-hospital mortality despite increased complications including hemolysis and cannulation site bleeding. Compared to pVAD, MU with IABP was associated with similar mortality and lower complication rates.
BACKGROUND: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) increases left ventricular (LV) afterload, potentially provoking LV distention and impairing recovery. LV mechanical unloading (MU) with intra-aortic balloon pump (IABP) or percutaneous ventricular assist device (pVAD) can prevent LV distension, potentially at the risk of more complications, and net clinical benefit remains uncertain. OBJECTIVES: This study aims to determine the association between MU and outcomes for patients undergoing VA-ECMO. METHODS: The authors queried the Extracorporeal Life Support Organization registry for adults receiving peripheral VA-ECMO from 2010 to 2019 and stratified them by MU with IABP or pVAD. The primary outcome was in-hospital mortality; secondary outcomes included on-support mortality and complications during VA-ECMO. RESULTS: Among 12,734 VA-ECMO patients, 3,399 (26.7%) received MU: 2,782 (82.9%) IABP and 580 (17.1%) pVAD. MU patients were older (age 56.3 vs 52.7 years) and, before extracorporeal membrane oxygenation, more often required >2 vasopressors (41.7% vs 27.2%) and had respiratory (21.1% vs 15.9%), renal (24.6% vs 15.8%), and liver failure (4.4% vs 3.1%) (all P < 0.001). MU patients had lower in-hospital mortality (56.6% vs 59.3%, P = 0.006), which persisted in multivariable modeling (adjusted OR [aOR]: 0.84; 95% CI: 0.77-0.92; P < 0.001). MU was associated with more cannula site bleeding (aOR: 1.25; 95% CI: 1.11-1.40; P < 0.001) and hemolysis (aOR: 1.27; 95% CI: 1.03-1.57; P = 0.02). Compared to pVAD, MU patients with IABP had similar mortality (aOR: 0.80; 95% CI: 0.64-1.01; P = 0.06) and less medical bleeding (aOR: 0.45; 95% CI: 0.31-0.64; P < 0.001), cannula site bleeding (aOR: 0.72; 95% CI: 0.54-0.96; P = 0.03), and renal injury (aOR: 0.78; 95% CI: 0.62-0.98; P = 0.03). CONCLUSIONS: Among adults receiving VA-ECMO, MU was associated with lower in-hospital mortality despite increased complications including hemolysis and cannulation site bleeding. Compared to pVAD, MU with IABP was associated with similar mortality and lower complication rates.
Authors: Lauren K Truby; Koji Takeda; Christine Mauro; Melana Yuzefpolskaya; Arthur R Garan; Ajay J Kirtane; Veli K Topkara; Darryl Abrams; Daniel Brodie; Paolo C Colombo; Yoshifumi Naka; Hiroo Takayama Journal: ASAIO J Date: 2017 May/Jun Impact factor: 2.872
Authors: Juan J Russo; Natasha Aleksova; Ian Pitcher; Etienne Couture; Simon Parlow; Mohammad Faraz; Sarah Visintini; Trevor Simard; Pietro Di Santo; Rebecca Mathew; Derek Y So; Koji Takeda; A Reshad Garan; Dimitrios Karmpaliotis; Hiroo Takayama; Ajay J Kirtane; Benjamin Hibbert Journal: J Am Coll Cardiol Date: 2019-02-19 Impact factor: 24.094
Authors: Sarah Tepper; Muhammad Faraz Masood; Moises Baltazar Garcia; Molly Pisani; Gregory A Ewald; John M Lasala; Richard G Bach; Jasvindar Singh; Keki R Balsara; Akinobu Itoh Journal: Ann Thorac Surg Date: 2017-03-25 Impact factor: 4.330
Authors: Dagmar M Ouweneel; Erlend Eriksen; Krischan D Sjauw; Ivo M van Dongen; Alexander Hirsch; Erik J S Packer; M Marije Vis; Joanna J Wykrzykowska; Karel T Koch; Jan Baan; Robbert J de Winter; Jan J Piek; Wim K Lagrand; Bas A J M de Mol; Jan G P Tijssen; José P S Henriques Journal: J Am Coll Cardiol Date: 2016-10-31 Impact factor: 24.094
Authors: Mabel Chung; Fausto R Cabezas; Jose I Nunez; Kevin F Kennedy; Katelyn Rick; Peter Rycus; Mandeep R Mehra; A Reshad Garan; Robb D Kociol; E Wilson Grandin Journal: JACC Heart Fail Date: 2020-11 Impact factor: 12.035
Authors: Sasa Rajsic; Benedikt Treml; Dragana Jadzic; Robert Breitkopf; Christoph Oberleitner; Marina Popovic Krneta; Zoran Bukumiric Journal: Ann Intensive Care Date: 2022-10-05 Impact factor: 10.318